share_log

UBS Initiates Coverage On Chimera Investment With Neutral Rating, Announces Price Target of $5.5

Benzinga ·  Dec 6, 2023 20:52

UBS analyst Douglas Harter initiates coverage on Chimera Investment (NYSE:CIM) with a Neutral rating and announces Price Target of $5.5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment